MediFind found 49 doctor with experience in Hyphema near Owings Mills, MD. Of these, 44 are Experienced, 4 are Advanced and 1 are Distinguished.
Patient First Maryland Medical Group PLLC
Faranak Moghadam is a primary care provider, practicing in Family Medicine in Owings Mills, Maryland. Dr. Moghadam is rated as an Advanced provider by MediFind in the treatment of Hyphema. Her top areas of expertise are Acute Cystitis, Bronchitis, Atypical Pneumonia, and Hospital-Acquired Pneumonia.
Patient First Maryland Medical Group PLLC
Victor Mcglaughlin is a primary care provider, practicing in Family Medicine in Owings Mills, Maryland. Dr. Mcglaughlin is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Acute Cystitis, Hospital-Acquired Pneumonia, Atypical Pneumonia, and Pneumonia.
Patient First Maryland Medical Group PLLC
Mark Paster is a primary care provider, practicing in Family Medicine in Owings Mills, Maryland. Dr. Paster is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Bronchitis, Parainfluenza, Parainfluenza Virus Type 3, and Multisystem Inflammatory Syndrome in Children (MIS-C). Dr. Paster is currently accepting new patients.
Patient First Maryland Medical Group PLLC
Boris Gronas is a primary care provider, practicing in Family Medicine in Owings Mills, Maryland. Dr. Gronas is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Acute Cystitis, Bronchitis, Flu, and Multisystem Inflammatory Syndrome in Children (MIS-C).
Patient First Maryland Medical Group PLLC
Bruce Kinzinger is a primary care provider, practicing in Family Medicine in Owings Mills, Maryland. Dr. Kinzinger is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Bronchitis, Acute Cystitis, Sinusitis, and COVID-19.
Brull And Honig MD PA
Marc Honig is an Ophthalmologist in Owings Mills, Maryland. Dr. Honig is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Cataract, Chalazion, Eyelid Bump, and Glaucoma. Dr. Honig is currently accepting new patients.
The Retina Care Center
Timothy D. Polk, MD, specializes in comprehensive ophthalmology. He is affiliated with UPMC Memorial. Dr. Polk completed his fellowships at the University of Iowa Hospitals and Clinics and Bascom Palmer Eye Institute, residency at Greater Baltimore Medical Center and medical degree at the University of Virginia School of Medicine. Dr. Polk is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, Retinal Vein Occlusion, and Vitrectomy.
Krieger Eye Institute
Dr. Stephen S. Pappas, Jr. is native to the Washington, D.C. area and has been in medical and surgical retinal practice for over 15 years. He is committed to providing personalized and compassionate retinal care, maintaining expertise and technology to offer the latest retinal treatments, and working closely with each patient’s medical team to preserve and restore vision. Dr. Pappas holds a B.A. from Bucknell University and earned his Medical Degree from George Washington University in 1989. Following his Ophthalmology Residency at the Washington Hospital Center, he pursued and completed his Clinical Fellowship training in Vitreoretinal diseases and surgery at the Retina Institute of Maryland (now known as the National Retina Institute) in Baltimore, MD, where he performed clinical research and participated in landmark clinical trials investigating both medical and surgical retinal treatments. Upon completion of his training in 1995, Dr. Pappas joined his father, one of the first fellowship-trained retina specialists in the Washington, D.C. area, in private group practice in Bethesda. In 2001, Dr. Pappas founded the Center for Retinal Diseases and Surgery, LLC, where he continues the tradition of personalized, compassionate retinal care established by his father nearly 50 years ago. Dr. Pappas is married with two children and resides in Montgomery County where he also serves as a trustee for two non-profit organizations. Recreationally, Dr. Pappas is an avid fan of his children’s sports and enjoys golf, skiing and holds a black belt in Tae Kwon Do. Learn more about Dr. Pappas by visiting his website . Dr. Pappas is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Blue Cone Monochromatism, Color Blindness, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).
The Johns Hopkins Hospital
James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as an Advanced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.
The Johns Hopkins Hospital
Mustafa Iftikhar, M.D., is the Stephen J. Ryan Assistant Chief of Service and assistant professor of ophthalmology at the Wilmer Eye Institute, Johns Hopkins Medicine. Dr. Iftikhar completed his ophthalmology residency at Wilmer, followed by a vitreoretinal surgery fellowship at Duke University Hospital. His clinical approach is rooted in patient-centered and evidence-based care. Dr. Iftikhar’s research interests include retinal diseases, ocular trauma, and healthcare disparities. He is deeply committed to surgical education and takes great pride in mentoring the next generation of ophthalmologists. Dr. Iftikhar is rated as an Advanced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Retinitis Pigmentosa, Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy.
Alan Robin is an Ophthalmologist in Baltimore, Maryland. Dr. Robin is rated as an Advanced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Cataract Removal, and Trabeculectomy.
The Johns Hopkins Hospital
Allen O. Eghrari, M.D., M.P.H., is director of the Dana Center for Preventive Ophthalmology at the Wilmer Eye Institute and associate professor of ophthalmology at the Johns Hopkins University School of Medicine. He specializes in cornea, cataract and external eye diseases at the Wilmer Eye Institute's locations in Baltimore and Belcamp, Maryland. Dr. Eghrari treats a wide range of eye conditions, with special interest in Fuchs' dystrophy, cataract surgery, cornea transplantation including Descemet Membrane Endothelial Keratoplasty, and Ebola-associated eye disease. Dr. Eghrari received his M.D. degree from the Johns Hopkins University School of Medicine and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed both residency training in ophthalmology and subspecialty fellowship in cornea and cataract surgery at the Wilmer Eye Institute. Dr. Eghrari is a recipient of the Claes Dohlman Society Fellowship Award, the ARVO/Alcon Early Career Clinician-Scientist Award, and the Research to Prevent Blindness Special Scholar Award. Dr. Eghrari is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.
The Johns Hopkins Hospital
Chris Cho is a General Surgeon and an Ophthalmologist in Baltimore, Maryland. Dr. Cho is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top area of expertise is Hyphema.
The Johns Hopkins Hospital
Fernando Arevalo is an Ophthalmologist in Baltimore, Maryland. Dr. Arevalo is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.
The Johns Hopkins Hospital
Dr. Pradeep Ramulu is a glaucoma specialist and the director of the Wilmer Eye Institute glaucoma division. He specializes in caring for both routine and complex glaucomas, including glaucomas requiring repeat operations, glaucoma occurring in the context of corneal or retinal disease and glaucoma occurring in newborns and young children. The Sheila K. West Professor of Ophthalmology at the Wilmer Eye Institute, Dr. Ramulu grew up in suburban Chicago, and became interested in the eye during medical school, during which time he studied the genes and proteins of the eye with Dr. Jeremy Nathans. After pursuing a residency in ophthalmology and fellowship training in glaucoma, he joined Wilmer in 2006. Dr. Ramulu is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Iridectomy, and Cataract Removal.
The Johns Hopkins Hospital
Jennifer Thorne, M.D., Ph.D., is the Cross Family Professor of Ophthalmology at the Wilmer Eye Institute, where she is also chief of the Division of Ocular Immunology. Dr. Thorne holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. An internationally recognized ophthalmologist, Dr. Thorne is an expert in the evaluation and management of patients with uveitis and other related immune-mediated disorders. Dr. Thorne also directs the Mucous Membrane Pemphigoid clinic, a multi-disciplinary specialty clinic designed to evaluate and treat patients with conjunctival diseases. Dr. Thorne's research interests include white dot syndromes including birdshot chorioretinitis, multifocal choroiditis and punctate inner choroiditis. She also studies juvenile idiopathic arthritis-related uveitis and treatment outcomes of immunosuppressive drug therapy. Dr. Thorne received her M.D. degree from the University of Virginia and completed her ophthalmology residency at the University of Pennsylvania's Scheie Eye Institute. She completed her uveitis fellowship at Wilmer and completed her Ph.D. in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Thorne is rated as an Experienced provider by MediFind in the treatment of Hyphema. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, Cataract Removal, and Vitrectomy.
The Johns Hopkins Hospital
Michael Sulewski, M.D., is the James and Heather Gills Rising Professor of Ophthalmology and a cornea and cataract specialist at the Wilmer Eye Institute’s Baltimore locations at Bayview Medical Center and the Patient Access Center for the Eye at The Johns Hopkins Hospital, as well as in White Marsh, Maryland. Dr. Sulewski is also the ophthalmology residency program director. Dr. Sulewski specializes in cataract surgery, intraocular lens complications, corneal transplantation, keratoprosthesis, refractive surgery and other medical and surgical diseases of the cornea and anterior segment of the eye. Dr. Sulewski is also a resident supervisor at the Wilmer Eye Institute Patient Center for the Eye at The Johns Hopkins Hospital. Recent News Articles and Media Coverage Five Questions for Michael Sulewski, Johns Hopkins Medicine (Dec. 2020). Dr. Sulewski is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Cataract, Cogan's Syndrome, Cloudy Cornea, and Keratoconus.
Morton Goldberg is an Ophthalmologist in Baltimore, Maryland. Dr. Goldberg is rated as a Distinguished provider by MediFind in the treatment of Hyphema. His top areas of expertise are Autosomal Dominant Vitreoretinochoroidopathy, Hyphema, Incontinentia Pigmenti, Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE), and Trabeculectomy.
The Johns Hopkins Hospital
Dr. Kraig Scot Bower is an associate professor of ophthalmology and the director of refractive surgery at the Wilmer Eye Institute. He specializes in refractive surgery (LASIK), cornea and external diseases of the eye and anterior segment surgery. Dr. Bower is a retired Army colonel, Medical Corps. From 2001 to 2010, he was the director of refractive surgery at Walter Reed Army Medical Center and served as the Army's refractive surgery subject matter expert, advising the Army Surgeon General on laser refractive surgery and managing the Army's Warfighter Refractive Eye Surgery Program. Dr. Bower is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Keratoconus, Astigmatism, Cataract, and Nearsightedness.
Chesapeake Eye Care And Laser Center LLC
Sumana Kommana is an Ophthalmologist in Baltimore, Maryland. Dr. Kommana is rated as an Experienced provider by MediFind in the treatment of Hyphema. Her top areas of expertise are Cataract, Nearsightedness, Interstitial Keratitis, and Astigmatism. Dr. Kommana is currently accepting new patients.
Last Updated: 02/22/2026








